Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
19 June 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Idecortex Articles
Briefs: Ablynx inks research deal with Spirogen; Solent Pharma debuts
25 February 2013
Showing 1-1 of 1 articles
1
Hot Topics
Most Read
US Supreme Court says patent settlement can "sometimes" be illegal
InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
Additional indications in Japan for Roche's Avastin and Astellas' Prograf
Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
US Supreme Court says patent settlement can "sometimes" be illegal
InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
Additional indications in Japan for Roche's Avastin and Astellas' Prograf
Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib